The global exoskeleton market size is estimated to be USD 0.7 billion in 2023 and is projected to reach USD 3.7 billion by 2028, at a CAGR of 38.6%. The growing adoption of robotic rehabilitation in healthcare and rising investment in the advancement of the exoskeleton are responsible for the growth of the exoskeleton market. Additionally, the rising insurance coverage for exoskeleton technology is also responsible for the markets growth.
Software segment is estimated to register the highest growth rate during the forecast period
The Software used in an exoskeleton is basically a set of coded commands and a list of instructions to program robots according to the task required to be performed by them. At present, a number of software packages suited to ergonomic simulation are available in the market. In response to the limitations of traditional design tools, software providers now offer a number of 3D CAD software packages for exoskeletons. These digital human modeling (DHM) software tools enable models of humans to interact with virtual products and workplaces in a CAD environment. Developers have boosted modeling and simulation capabilities, enabling designers to develop exoskeletons with better cost efficiency for broader adoption.
Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=40697797
Passive segment to hold second-largest CAGR in the coming years
Passive exoskeletons, in comparison to powered exoskeletons, have simpler structures, lower production costs, and require no electric power. These exoskeletons utilize a wearers strength and save energy of the wearer when in motion. Passive exoskeletons support the upper limbs of the patient as they reduce the gravitational load and offer the user the chance to perform the necessary rehabilitation tasks. These exoskeletons are widely used for ergonomic support in order to prevent users from repetitive stress injuries and help them hold equipment and tools.
Europe to account for the second-largest market share during the forecast period
Europe is expected to be the second leading region in the exoskeleton market during the forecast period. In Europe, Exoskeletons have shown a disruptive effect on the competitiveness of non-manufacturing industries such as logistics, healthcare, and education. These non-manufacturing industries are adopting exoskeleton systems at large for rehabilitation, pick and carry, and other applications. Additionally, improving economic conditions, coupled with the rising demand for intelligent sensors for quality interaction between human and robotic devices, is expected to boost the exoskeleton market growth in Europe. One of the key factors driving the growth of the exoskeleton market is strong interdisciplinary research along the value chain of robotics in Europe.
Major companies operating in this exoskeleton market include CYBERDYNE INC. (Japan), Lockheed Martin Corporation (US), Ottobock (Germany), Ekso Bionics (US), DIH Medical (China), Sarcos Technology and Robotics Corporation (US), BIONIK (US), and B-Temia (Canada). The study includes an in-depth competitive analysis of these key players in the exoskeleton market with their company profiles, recent developments, and key market strategies.
Recent Developments in Exoskeleton Industry
In December 2022, Ekso Bionics announced the acquisition of the Human Motion and Control business unit from Parker Hannifin Corporation. The acquisition includes the Indego lower limb exoskeleton line of products as well as the planned development of robotic-assisted orthotic and prosthetic devices. This complementary acquisition expands Ekso's product offerings across the continuum of care to home and community use markets grow Ekso's product pipeline and adds strategic relationships with key commercial and research partners, including Vanderbilt University.
In April 2022, Ottobock announced the launch of Ottobock Shoulder, a next-generation exoskeleton. It provides support during strenuous over-the-shoulder activities in logistics, production, maintenance, and handcraft. The new exoskeleton is a further development of the Paexo Shoulder.
Know more information @ https://www.marketsandmarkets.com/Market-Reports/exoskeleton-market-40697797.html
About MarketsandMarkets
MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Aashish Mehra
MarketsandMarkets INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
No comments:
Post a Comment